Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.57 |
| ▸ | TOP2A | P11388 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.46 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.46 |
| ▸ | PTPRF | P10586 | 1/20 | 0.46 |
| ▸ | ACP1 | P24666 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahymanol SCHEMBL5831685 | 1.00 | PTPN1 (0.57) | PTPN1TOP2AHIF1ACES2CES1 | |
| SCHEMBL29501291 | 0.85 | PTPN1 (0.68) | PTPN1HIF1A | |
| SCHEMBL17867180 | 0.81 | PTPN1 (0.53) | PTPN1TOP2AHIF1ACES2CES1 | |
| SCHEMBL18760924 | 0.81 | PTPN1 (0.53) | PTPN1TOP2AHIF1ACES2CES1 | |
| SCHEMBL16433264 | 0.80 | PTPN1 (0.49) | PTPN1HIF1APTPRFACP1RELA | |
| SCHEMBL29400217 | 0.77 | PTPN1 (0.67) | PTPN1TOP2AHIF1ACES2CES1 | |
| SCHEMBL28453559 | 0.77 | PTPN1 (0.67) | PTPN1TOP2AHIF1ACES2CES1 | |
| Hopenol B SCHEMBL29985737 | 0.76 | PTPN1 (0.69) | PTPN1TOP2AHIF1ACES2CES1 | |
| Hopenol B SCHEMBL30036559 | 0.76 | PTPN1 (0.69) | PTPN1TOP2AHIF1ACES2CES1 | |
| SCHEMBL17867237 | 0.75 | SLC10A1 (0.55) | PTPN1TOP2AHIF1ACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009064-A1 | STEROL PRODUCTION IN YEAST | Apix Biosciences (BE) | 2026-01-08 | — | — | US | claimed |
| WO-2023089317-A1 | STEROL PRODUCTION IN YEAST | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-05-25 | — | — | WO | claimed |
| WO-2021133171-A1 | RECOMBINANT FUNGAL CELL | TECHNISCHE UNIVERSITEIT DELFT (NL) | 2021-07-01 | — | — | WO | claimed |
| WO-2021072473-A1 | ANTIMICROBIALS AS FEED PRESERVATIVES | IRP Health Pty Ltd (AU) | 2021-04-22 | — | — | WO | claimed |
| US-20030207317-A1 | Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use | RUSING MATTHIAS (DE) | 2003-11-06 | — | — | US | claimed |
| US-20020031797-A1 | Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use | NUTRINOVA, NUTRITION SPECIALTIES & FOOD (DE) | 2002-03-14 | — | — | US | claimed |
| US-20260009064-A1 | STEROL PRODUCTION IN YEAST | Apix Biosciences (BE) | 2026-01-08 | — | — | US | disclosed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20240397979-A1 | METHODS FOR DELIVERING BENEFICIAL NUTRIENTS TO INVERTEBRATES THROUGH A MICROORGANISM DEFICIENT IN ANTINUTRIENTS | Apix Biosciences (BE) | 2024-12-05 | — | — | US | disclosed |
| US-20240389618-A1 | METHODS FOR DELIVERING 24-METHYLENE CHOLESTEROL, ISOFUCOSTEROL, CHOLESTEROL OR DESMOSTEROL TO INVERTEBRATES, IN PARTICULAR HONEY BEES OR BUMBLE BEES | Apix Biosciences (BE) | 2024-11-28 | — | — | US | disclosed |
| EP-4408190-A1 | METHODS FOR DELIVERING 24-METHYLENE CHOLESTEROL, ISOFUCOSTEROL, CHOLESTEROL OR DESMOSTEROL TO INVERTEBRATES, IN PARTICULAR HONEY BEES OR BUMBLE BEES | APIX BIOSCIENCES (BE) | 2024-08-07 | — | — | EP | disclosed |
| WO-2024092274-A2 | ENDOCYTIC AGENTS | BIOVENTURES, LLC (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023089317-A1 | STEROL PRODUCTION IN YEAST | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-05-25 | — | — | WO | disclosed |
| US-20030207317-A1 | Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use | RUSING MATTHIAS (DE) | 2003-11-06 | — | — | US | disclosed |
| US-6534100-B1 | Methods for treating cholesterol-containing foodstuffs using live ciliates | VALCARCE GERMAN A (AR) | 2003-03-18 | — | — | US | disclosed |
| EP-1251167-A2 | Delta 7 and delta 22 cholesterol desaturases from ciliata phylum, and uses | Valcarce, German A. (AR) | 2002-10-23 | — | — | EP | disclosed |
| US-6391351-B2 | REDUCING THE LEVEL OF CHOLESTEROL AND INCREASING DELTA 7 OR 22 DEHYDROCHOLESTEROL AND/OR DELTA 7, 22 BISDEHYDROCHOLESTEROL BY INCUBATION WITH FRACTIONS OF THE TETRAHYMENIDAE FAMILY | VALCARCE GERMAN A (AR) | 2002-05-21 | — | — | US | disclosed |
| US-20020031797-A1 | Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use | NUTRINOVA, NUTRITION SPECIALTIES & FOOD (DE) | 2002-03-14 | — | — | US | disclosed |
| US-20020009519-A1 | Methods for treating foodstuffs using cell free extracts from ciliates | VALCARCE GERMAN A (AR) | 2002-01-24 | — | — | US | disclosed |
| WO-2001019201-A1 | METHODS FOR TREATING CHOLESTEROL-CONTAINING FOODSTUFFS USING LIVE CILIATES | FLORIN CHRISTENSEN JORGE (US) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009064-A1 | STEROL PRODUCTION IN YEAST | SREBF2, ERG28, SREBF1 | PTPN1 2240/4885TOP2A 3349/4885HIF1A 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.